US Stock MarketDetailed Quotes

Taysha Gene Therapies (TSHA)

Watchlist
  • 5.090
  • +0.310+6.49%
Close Jan 22 16:00 ET
  • 5.070
  • -0.020-0.39%
Post 18:23 ET
1.39BMarket Cap-15.42P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taysha Gene Therapies (TSHA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
78.60%1.99M
-32.51%2.3M
-46.07%8.33M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
517.55%15.45M
44.04%3.6M
Operating revenue
--0
78.60%1.99M
-32.51%2.3M
-46.07%8.33M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
517.55%15.45M
44.04%3.6M
Cost of revenue
Gross profit
Operating expense
48.91%34.02M
28.24%28.74M
-14.48%23.72M
9.36%94.95M
13.16%21.95M
12.11%22.85M
-13.06%22.41M
30.45%27.74M
-32.45%86.83M
-3.23%19.4M
Selling and administrative expenses
4.77%8.28M
17.17%8.6M
15.16%8.16M
-3.64%28.95M
-1.34%6.63M
-8.00%7.9M
22.55%7.34M
-19.05%7.08M
-19.57%30.05M
-8.47%6.72M
-General and administrative expense
4.77%8.28M
17.17%8.6M
15.16%8.16M
-3.64%28.95M
-1.34%6.63M
-8.00%7.9M
22.55%7.34M
-19.05%7.08M
-19.57%30.05M
-8.47%6.72M
Research and development costs
72.25%25.75M
33.62%20.14M
-24.65%15.57M
16.24%66M
20.84%15.33M
26.76%14.95M
-23.84%15.07M
65.07%20.66M
-37.72%56.78M
-0.20%12.68M
Operating profit
-61.56%-34.02M
-25.61%-26.75M
11.96%-21.42M
-21.36%-86.62M
-26.18%-19.93M
-34.71%-21.06M
8.92%-21.3M
-46.93%-24.33M
43.37%-71.37M
9.97%-15.8M
Net non-operating interest income expense
51.42%3.15M
30.36%1.84M
-21.45%1.31M
579.52%6.84M
38.91%1.68M
675.41%2.08M
216.11%1.41M
257.73%1.66M
59.82%-1.43M
209.22%1.21M
Non-operating interest income
50.40%3.17M
29.10%1.86M
-21.68%1.33M
94.29%6.94M
-11.50%1.7M
89.99%2.11M
545.74%1.44M
430.72%1.69M
1,334.54%3.57M
865.33%1.92M
Non-operating interest expense
-37.50%15K
-37.04%17K
-34.48%19K
-97.96%102K
-96.91%22K
-98.37%24K
-98.13%27K
-97.89%29K
31.60%5M
-45.36%713K
Other net income (expense)
71.54%-1.86M
-89.16%-1.97M
-1.43%-1.42M
75.46%-9.52M
-100.85%-531K
93.52%-6.55M
-34,833.33%-1.04M
-17,337.50%-1.4M
-6.39%-38.77M
271.11%62.33M
Gain on sale of security
-489.33%-292K
-240.00%-273K
130.27%102K
100.05%16K
-99.87%83K
100.07%75K
--195K
---337K
---34.72M
--65.74M
Special income (charges)
--0
----
----
-96.43%-4.84M
--0
-685.39%-4.84M
----
----
93.24%-2.46M
94.93%-1.85M
-Less:Impairment of capital assets
--0
----
----
354.27%4.84M
--0
685.39%4.84M
----
----
-97.08%1.07M
-98.77%449K
-Less:Other special charges
----
----
----
----
----
----
----
----
--1.4M
----
Other non- operating income (expenses)
11.94%-1.57M
-37.27%-1.7M
-43.38%-1.52M
-196.09%-4.69M
60.67%-614K
-9,289.47%-1.78M
-41,333.33%-1.24M
-13,125.00%-1.06M
-8,705.56%-1.59M
-25,916.67%-1.56M
Income before tax
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
Income tax
Net income
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
Net income continuous Operations
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
Minority interest income
Net income attributable to the parent company
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
Basic earnings per share
10.00%-0.09
0.00%-0.09
20.00%-0.08
62.50%-0.36
-127.41%-0.07
89.25%-0.1
76.32%-0.09
64.29%-0.1
74.60%-0.96
125.79%0.2554
Diluted earnings per share
10.00%-0.09
0.00%-0.09
20.00%-0.08
62.50%-0.36
-127.41%-0.07
89.25%-0.1
76.32%-0.09
64.29%-0.1
74.60%-0.96
125.79%0.2554
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 078.60%1.99M-32.51%2.3M-46.07%8.33M-43.90%2.02M-62.33%1.79M-53.57%1.11M-27.52%3.41M517.55%15.45M44.04%3.6M
Operating revenue --078.60%1.99M-32.51%2.3M-46.07%8.33M-43.90%2.02M-62.33%1.79M-53.57%1.11M-27.52%3.41M517.55%15.45M44.04%3.6M
Cost of revenue
Gross profit
Operating expense 48.91%34.02M28.24%28.74M-14.48%23.72M9.36%94.95M13.16%21.95M12.11%22.85M-13.06%22.41M30.45%27.74M-32.45%86.83M-3.23%19.4M
Selling and administrative expenses 4.77%8.28M17.17%8.6M15.16%8.16M-3.64%28.95M-1.34%6.63M-8.00%7.9M22.55%7.34M-19.05%7.08M-19.57%30.05M-8.47%6.72M
-General and administrative expense 4.77%8.28M17.17%8.6M15.16%8.16M-3.64%28.95M-1.34%6.63M-8.00%7.9M22.55%7.34M-19.05%7.08M-19.57%30.05M-8.47%6.72M
Research and development costs 72.25%25.75M33.62%20.14M-24.65%15.57M16.24%66M20.84%15.33M26.76%14.95M-23.84%15.07M65.07%20.66M-37.72%56.78M-0.20%12.68M
Operating profit -61.56%-34.02M-25.61%-26.75M11.96%-21.42M-21.36%-86.62M-26.18%-19.93M-34.71%-21.06M8.92%-21.3M-46.93%-24.33M43.37%-71.37M9.97%-15.8M
Net non-operating interest income expense 51.42%3.15M30.36%1.84M-21.45%1.31M579.52%6.84M38.91%1.68M675.41%2.08M216.11%1.41M257.73%1.66M59.82%-1.43M209.22%1.21M
Non-operating interest income 50.40%3.17M29.10%1.86M-21.68%1.33M94.29%6.94M-11.50%1.7M89.99%2.11M545.74%1.44M430.72%1.69M1,334.54%3.57M865.33%1.92M
Non-operating interest expense -37.50%15K-37.04%17K-34.48%19K-97.96%102K-96.91%22K-98.37%24K-98.13%27K-97.89%29K31.60%5M-45.36%713K
Other net income (expense) 71.54%-1.86M-89.16%-1.97M-1.43%-1.42M75.46%-9.52M-100.85%-531K93.52%-6.55M-34,833.33%-1.04M-17,337.50%-1.4M-6.39%-38.77M271.11%62.33M
Gain on sale of security -489.33%-292K-240.00%-273K130.27%102K100.05%16K-99.87%83K100.07%75K--195K---337K---34.72M--65.74M
Special income (charges) --0---------96.43%-4.84M--0-685.39%-4.84M--------93.24%-2.46M94.93%-1.85M
-Less:Impairment of capital assets --0--------354.27%4.84M--0685.39%4.84M---------97.08%1.07M-98.77%449K
-Less:Other special charges ----------------------------------1.4M----
Other non- operating income (expenses) 11.94%-1.57M-37.27%-1.7M-43.38%-1.52M-196.09%-4.69M60.67%-614K-9,289.47%-1.78M-41,333.33%-1.24M-13,125.00%-1.06M-8,705.56%-1.59M-25,916.67%-1.56M
Income before tax -28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M
Income tax
Net income -28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M
Net income continuous Operations -28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M
Minority interest income
Net income attributable to the parent company -28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M
Basic earnings per share 10.00%-0.090.00%-0.0920.00%-0.0862.50%-0.36-127.41%-0.0789.25%-0.176.32%-0.0964.29%-0.174.60%-0.96125.79%0.2554
Diluted earnings per share 10.00%-0.090.00%-0.0920.00%-0.0862.50%-0.36-127.41%-0.0789.25%-0.176.32%-0.0964.29%-0.174.60%-0.96125.79%0.2554
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -